Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    evonik-m-2025-09-08

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Menu

    Vonicog Alfa

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    1st & only recombinant VWF recommended for routine commissioning via NHS England
    1st & only recombinant VWF recommended for routine commissioning via NHS England

    25 Sep 2020

    // PRNEWSWIRE

    https://www.prnewswire.co.uk/news-releases/first-and-only-recombinant-von-willebrand-factor-treatment-for-adults-with-von-willebrand-disease-the-most-common-inherited-bleeding-disorder-1-recommended-for-routine-commissioning-via-nhs-england-814703238.html

    PRNEWSWIRE
    25 Sep 2020
    Share Share
    Baxalta's Veyvondi (vonicog alfa) Receives Approval in Europe
    Baxalta's Veyvondi (vonicog alfa) Receives Approval in Europe

    22 Sep 2018

    // EMA

    http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/004454/WC500255625.pdf

    EMA
    22 Sep 2018
    Share Share
    Shire’s Veyvondi approved in Europe for bleeding disorder
    Shire’s Veyvondi approved in Europe for bleeding disorder

    12 Sep 2018

    // Selina McKee PHARMA TIMES

    http://www.pharmatimes.com/news/shires_veyvondi_approved_in_europe_for_bleeding_disorder_1251914

    Selina McKee PHARMA TIMES
    12 Sep 2018
    Share Share